Quantinuum (NASDAQ:QNT) Stock Price Target Cut by Jefferies Financial Group

Posted by George Bondi on Nov 6th, 2026

Quantinuum (NASDAQ:QNT – Get Free Report) had its target price dropped by equities research analysts at Jefferies Financial Group from $85.00 to $65.00 in a research report issued to clients and investors on Friday, Benzinga reports. The firm currently has a “buy” rating on the stock. Jefferies Financial Group‘s target price would indicate a potential upside of 73.01% from the company’s current price.

QNT has been the subject of a number of other research reports. Weiss Ratings assumed coverage on Quantinuum in a research report on Monday, August 31st. They set a “sell (d)” rating for the company. JPMorgan Chase & Co. cut their price objective on Quantinuum from $97.00 to $80.00 and set an “overweight” rating on the stock in a research report on Friday. Cantor Fitzgerald reduced their target price on Quantinuum from $90.00 to $55.00 and set an “overweight” rating on the stock in a research note on Friday. Yorkville Ives started coverage on Quantinuum in a research note on Monday, October 5th. They set an “outperform” rating and a $60.00 target price on the stock. Finally, Needham & Company LLC decreased their target price on Quantinuum from $100.00 to $60.00 and set a “buy” rating for the company in a report on Friday. Thirteen equities research analysts have rated the stock with a Buy rating, two have given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $85.62.

Get Our Latest Stock Report on QNT

Quantinuum Stock Up 26.0%

NASDAQ:QNT traded up $7.75 during midday trading on Friday, reaching $37.57. 5,036,156 shares of the stock traded hands, compared to its average volume of 2,310,231. The firm has a market capitalization of $9.89 billion and a PE ratio of -134.18. The business has a fifty day moving average of $43.41. Quantinuum has a 12 month low of $28.31 and a 12 month high of $86.79.

Quantinuum (NASDAQ:QNT – Get Free Report) last posted its earnings results on Thursday, November 5th. The company reported ($0.29) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.99) by $0.70. The firm had revenue of $9.05 million for the quarter. As a group, analysts forecast that Quantinuum will post -4.76 EPS for the current fiscal year.

Institutional Investors Weigh In On Quantinuum

Hedge funds and other institutional investors have recently bought and sold shares of the business. Russell Investments Group Ltd. purchased a new position in shares of Quantinuum in the 3rd quarter worth about $97,000. Pier 88 Investment Partners LLC purchased a new stake in Quantinuum during the 3rd quarter valued at about $154,000. Fifth Third Bancorp grew its position in Quantinuum by 1,530.2% during the 3rd quarter. Fifth Third Bancorp now owns 1,027 shares of the company’s stock valued at $49,000 after purchasing an additional 964 shares during the last quarter. State of Wyoming bought a new stake in Quantinuum during the 3rd quarter valued at about $378,000. Finally, Flagship Harbor Advisors LLC bought a new stake in Quantinuum during the 3rd quarter valued at about $206,000.

Key Quantinuum News

Here are the key news stories impacting Quantinuum this week:

Positive Sentiment: Quantinuum beat third-quarter expectations, reporting a loss of $0.29 per share versus the $0.99 loss analysts expected. Revenue rose 233% year over year to $9.05 million, and the company raised its full-year 2026 revenue outlook. The report also noted that gross margin turned positive, although expenses are increasing. Quantinuum Q3 results and outlook
Positive Sentiment: Commercial traction strengthened: Quantinuum said it secured its largest cloud agreement to date, expanded access through a hyperscaler and an Oracle beta launch, and saw platform adoption rise nearly 20% quarter over quarter. These developments could help build future revenue. Quantinuum Q3 results and outlook
Positive Sentiment: The company outlined its Nexus developer-platform roadmap, connecting application development with future hardware, including its planned Apollo fault-tolerant quantum computer. The roadmap and reported technical milestones could strengthen Quantinuum’s longer-term competitive position. Nexus roadmap announcement
Negative Sentiment: Some analysts lowered their forecasts and price targets after the results. Cantor Fitzgerald cut its target from $90 to $55 and Needham lowered its target from $100 to $60, though both retained positive ratings—Overweight and Buy, respectively. The cuts may temper enthusiasm despite the earnings beat. Analysts cut forecasts after Q3 results

About Quantinuum

(Get Free Report)

Quantinuum is a quantum computing company formed in 2021 through the combination of Honeywell Quantum Solutions and Cambridge Quantum. The company develops full-stack quantum computing technologies designed to support research and commercial applications across industries, including chemistry, materials science, cybersecurity, finance and artificial intelligence.

Its offerings include trapped-ion quantum computers, quantum software and development tools. Quantinuum’s software portfolio includes the TKET quantum compiler, InQuanto quantum chemistry platform, Quantum Origin quantum-enhanced cybersecurity solutions and the Nexus platform for developing and managing quantum applications.